Biodefense Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

The global biodefense market continues to expand as nations worldwide confront escalating biological threats, rising bioterrorism concerns, and increasingly frequent infectious disease outbreaks. According to the latest assessment, the biodefense market size reached USD 15.39 billion in 2024, is projected to grow to USD 16.23 billion in 2025, and is expected to further surge to USD 24.64 billion by 2032, reflecting a CAGR of 6.1% during the forecast period. North America dominated the landscape in 2024 with a 42.88% market share, driven by advanced infrastructure, robust government programs, and strong private-public collaborations.

Biodefense encompasses the detection, prevention, and mitigation of biological threats-whether naturally occurring, accidental, or intentional. From military preparedness to civilian protection, biodefense systems involve biosurveillance, diagnostic tools, vaccines, decontamination technology, and emergency response capabilities. Increasing geopolitical tensions, such as those escalated by the Russia-Ukraine conflict, further emphasize the urgency for global biodefense preparedness.

Market Drivers

A key driver behind market growth is the heightened global awareness of biological risks. The recurrence of pandemics and infectious diseases, coupled with advances in synthetic biology and high-risk bioengineering capabilities, has prompted governments to expand biodefense budgets. Pharmaceutical and biotechnology companies are accelerating vaccine development, diagnostics innovation, and therapeutic research to strengthen national security readiness.

Governments worldwide are investing heavily in biodefense infrastructure. Notably, in April 2025, Parsons Corporation secured a USD 24 million U.S. Naval Medical Research Command contract to advance infectious disease detection technologies. Innovations in AI, machine learning, biosensors, and IoT systems are transforming biodefense by improving surveillance efficiency and enabling real-time threat analysis.

Market Restraints

Despite strong momentum, the market faces challenges including high R&D costs, long approval timelines, and uncertainty surrounding commercial viability. Because many biodefense products target rare pathogens with limited real-world outbreak data, companies encounter difficulties in conducting large-scale trials.

Moreover, without guaranteed government procurement programs, recovering development investments becomes uncertain. Liability concerns, highly regulated pathways, and stringent biosafety rules also limit participation-particularly among smaller biotech firms.

Market Opportunities

The rising prevalence of outbreaks such as COVID-19, Ebola, and mpox has underscored the need for rapid-response vaccines, therapeutics, and advanced biosurveillance systems. This is creating new opportunities for technology developers, particularly in genomics, AI-driven threat prediction, and portable detection systems.

Increasing collaboration between governments, biotech firms, and research institutions is strengthening capability-building efforts. The global shift toward digital biosecurity, early warning systems, and next-generation biosensors is expected to be a major opportunity for industry players over the next decade.

Market Trends

A significant trend shaping the market is the growing adoption of advanced surveillance and disinfection technologies. UV light systems led the market by technology in 2024 due to their effectiveness in microbial inactivation and strong demand for rapid sterilization tools. Biosensors are expected to be the fastest-growing system segment, enabling accurate, real-time threat detection across military, border control, and clinical applications.

Breakthroughs in synthetic biology, rapid diagnostics, genomics, and vector-based vaccines are also transforming biodefense preparedness. In February 2022, TeselaGen Biotechnology signed a collaboration with BioMADE to enhance AI-driven fermentation biomanufacturing platforms-highlighting the rising convergence of biotechnology and artificial intelligence in biodefense.

Segmentation Overview

Technology:

UV light dominated in 2024 and remains the fastest-growing technology due to high demand for disinfection. Gamma radiation, cold plasma, and microwave heating are also expanding applications, particularly in sterilization and decontamination.

System:

Biohazard detection systems accounted for the largest share in 2024, driven by rising bioterrorism and outbreak concerns. Biosensors will grow the fastest from 2025-2032 due to rapid miniaturization and field operability.

End User:

Military forces held the largest share in 2024, reflecting heightened global security concerns. Pharmaceutical & biotech companies are expected to be the fastest-growing segment due to increased investment in vaccines and therapeutics.

Regional Insights

North America remained the largest regional market in 2024, valued at USD 6.60 billion, supported by programs such as Project BioShield and BARDA. Frequent investments from NIH, CDC, and the DoD-such as SIGA Technologies' DOD contract for TPOXX in 2024-continue to strengthen the region's market leadership.

Europe is projected to be the fastest-growing region, driven by strong government funding, HERA initiatives, and major contracts such as Smiths Detection's USD 89.6 million MoD award for chemical threat detection.

Asia Pacific presents lucrative opportunities due to rising disease outbreaks, military modernization, and expanded biosurveillance investments.

Conclusion

Given rising biological threats, geopolitical instability, and rapid advances in biotechnology, the biodefense market is set to grow steadily from USD 15.39 billion in 2024 to USD 24.64 billion by 2032. Increasing global funding, technological innovation, and the demand for rapid detection and response systems will play central roles in shaping market evolution.

By Segmentation By Technology

UV Light
Gamma Radiation
Cold Plasma
Microwave Heating
Others

By System

Digital Biosurveillance Networks
Early Warning Systems
Biohazard Detection Systems
AI-Assisted Surveillance System
Biosensors
Others

By End User

Military Forces
Homeland Security
Hospitals & Clinics
Pharmaceutical & Biotech Companies
Virological Research Institutes

By Region

North America (By Technology, By System, By End User, By Country)
- U.S. (By End User)
- Canada (By End User)
Europe (By Technology, By System, By End User, By Country)
- U.K. (By End User)
- Germany (By End User)
- France (By End User)
- Russia (By End User)
- Rest of Europe (By End User)
Asia Pacific (By Technology, By System, By End User, By Country)
- China (By End User)
- India (By End User)
- Japan (By End User)
- South Korea (By End User)
- Rest of Asia Pacific (By End User)
Middle East & Africa (By Technology, By System, By End User, By Country)
Iran (By End User)
- Israel (By End User)
- Saudi Arabia (By End User)
- Turkey (By End User)
- Rest of Middle East & Africa (By End User)
Latin America (By Technology, By System, By End User, By Country)
- Brazil (By End User)
- Argentina (By End User)
- Mexico (By End User)
- Rest of Latin America (By End User)

Product Code: FBI113684

Table of Content

1. Introduction

1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends

4. Key Insights

4.1. Key Industry Developments - Key Contracts & Agreements, Mergers, Acquisitions and Partnerships
4.2. Latest Technological Advancements
4.3. Porters Five Forces Analysis
4.4. Supply Chain Analysis
4.5. Qualitative Insights - Impact of COVID-19 Pandemic on Global Biodefense Market
4.6. Regulatory Analysis on Global Biodefense Market

5. Global Biodefense Market Analysis, Insights and Forecast, 2019-2032

5.1. Key Findings / Definition
5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Microwave Heating
- 5.2.2. UV Light
- 5.2.3. Gamma Radiation
- 5.2.4. Cold Plasma
- 5.2.5. Others
5.3. Market Analysis, Insights and Forecast - By System
- 5.3.1. Digital Biosurveillance Networks
- 5.3.2. Early Warning Systems
- 5.3.3. Biohazard Detection Systems
- 5.3.4. AI-Assisted Surveillance System
- 5.3.5. Biosensors
- 5.3.6. Others
5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Military Forces
- 5.4.2. Homeland Security
- 5.4.3. Hospitals & Clinics
- 5.4.4. Pharmaceutical & Biotech Companies
- 5.4.5. Virological Research Institutes
5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Middle East & Africa
- 5.5.5. Latin America

6. North America Biodefense Market Analysis, Insights and Forecast, 2019-2032

6.1. Market Analysis, Insights and Forecast - By Technology
- 6.1.1. Microwave Heating
- 6.1.2. UV Light
- 6.1.3. Gamma Radiation
- 6.1.4. Cold Plasma
- 6.1.5. Others
6.2. Market Analysis, Insights and Forecast - By System
- 6.2.1. Digital Biosurveillance Networks
- 6.2.2. Early Warning Systems
- 6.2.3. Biohazard Detection Systems
- 6.2.4. AI-Assisted Surveillance System
- 6.2.5. Biosensors
- 6.2.6. Others
6.3. Market Analysis, Insights and Forecast - By End User
- 6.3.1. Military Forces
- 6.3.2. Homeland Security
- 6.3.3. Hospitals & Clinics
- 6.3.4. Pharmaceutical & Biotech Companies
- 6.3.5. Virological Research Institutes
6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
  - 6.4.1.1. Market Analysis, Insights and Forecast - By End User
    - 6.4.1.1.1. Military Forces
    - 6.4.1.1.2. Homeland Security
    - 6.4.1.1.3. Hospitals & Clinics
    - 6.4.1.1.4. Pharmaceutical & Biotech Companies
    - 6.4.1.1.5. Virological Research Institutes
- 6.4.2. Canada
  - 6.4.2.1. Market Analysis, Insights and Forecast - By End User
    - 6.4.2.1.1. Military Forces
    - 6.4.2.1.2. Homeland Security
    - 6.4.2.1.3. Hospitals & Clinics
    - 6.4.2.1.4. Pharmaceutical & Biotech Companies
    - 6.4.2.1.5. Virological Research Institutes

7. Europe Biodefense Market Analysis, Insights and Forecast, 2019-2032

7.1. Market Analysis, Insights and Forecast - By Technology
- 7.1.1. Microwave Heating
- 7.1.2. UV Light
- 7.1.3. Gamma Radiation
- 7.1.4. Cold Plasma
- 7.1.5. Others
7.2. Market Analysis, Insights and Forecast - By System
- 7.2.1. Digital Biosurveillance Networks
- 7.2.2. Early Warning Systems
- 7.2.3. Biohazard Detection Systems
- 7.2.4. AI-Assisted Surveillance System
- 7.2.5. Biosensors
- 7.2.6. Others
7.3. Market Analysis, Insights and Forecast - By End User
- 7.3.1. Military Forces
- 7.3.2. Homeland Security
- 7.3.3. Hospitals & Clinics
- 7.3.4. Pharmaceutical & Biotech Companies
- 7.3.5. Virological Research Institutes
7.4. Market Analysis, Insights and Forecast - By Country
- 7.4.1. U.K.
  - 7.4.1.1. Market Analysis, Insights and Forecast - By End User
    - 7.4.1.1.1. Military Forces
    - 7.4.1.1.2. Homeland Security
    - 7.4.1.1.3. Hospitals & Clinics
    - 7.4.1.1.4. Pharmaceutical & Biotech Companies
    - 7.4.1.1.5. Virological Research Institutes
- 7.4.2. Germany
  - 7.4.2.1. Market Analysis, Insights and Forecast - By End User
    - 7.4.2.1.1. Military Forces
    - 7.4.2.1.2. Homeland Security
    - 7.4.2.1.3. Hospitals & Clinics
    - 7.4.2.1.4. Pharmaceutical & Biotech Companies
    - 7.4.2.1.5. Virological Research Institutes
- 7.4.3. France
  - 7.4.3.1. Market Analysis, Insights and Forecast - By End User
    - 7.4.3.1.1. Military Forces
    - 7.4.3.1.2. Homeland Security
    - 7.4.3.1.3. Hospitals & Clinics
    - 7.4.3.1.4. Pharmaceutical & Biotech Companies
    - 7.4.3.1.5. Virological Research Institutes
- 7.4.4. Russia
  - 7.4.4.1. Market Analysis, Insights and Forecast - By End User
    - 7.4.4.1.1. Military Forces
    - 7.4.4.1.2. Homeland Security
    - 7.4.4.1.3. Hospitals & Clinics
    - 7.4.4.1.4. Pharmaceutical & Biotech Companies
    - 7.4.4.1.5. Virological Research Institutes
- 7.4.5. Rest of Europe
  - 7.4.5.1. Market Analysis, Insights and Forecast - By End User
    - 7.4.5.1.1. Military Forces
    - 7.4.5.1.2. Homeland Security
    - 7.4.5.1.3. Hospitals & Clinics
    - 7.4.5.1.4. Pharmaceutical & Biotech Companies
    - 7.4.5.1.5. Virological Research Institutes

8. Asia Pacific Biodefense Market Analysis, Insights and Forecast, 2019-2032

8.1. Market Analysis, Insights and Forecast - By Technology
- 8.1.1. Microwave Heating
- 8.1.2. UV Light
- 8.1.3. Gamma Radiation
- 8.1.4. Cold Plasma
- 8.1.5. Others
8.2. Market Analysis, Insights and Forecast - By System
- 8.2.1. Digital Biosurveillance Networks
- 8.2.2. Early Warning Systems
- 8.2.3. Biohazard Detection Systems
- 8.2.4. AI-Assisted Surveillance System
- 8.2.5. Biosensors
- 8.2.6. Others
8.3. Market Analysis, Insights and Forecast - By End User
- 8.3.1. Military Forces
- 8.3.2. Homeland Security
- 8.3.3. Hospitals & Clinics
- 8.3.4. Pharmaceutical & Biotech Companies
- 8.3.5. Virological Research Institutes
8.4. Market Analysis, Insights and Forecast - By Country
- 8.4.1. China
  - 8.4.1.1. Market Analysis, Insights and Forecast - By End User
    - 8.4.1.1.1. Military Forces
    - 8.4.1.1.2. Homeland Security
    - 8.4.1.1.3. Hospitals & Clinics
    - 8.4.1.1.4. Pharmaceutical & Biotech Companies
    - 8.4.1.1.5. Virological Research Institutes
- 8.4.2. India
  - 8.4.2.1. Market Analysis, Insights and Forecast - By End User
    - 8.4.2.1.1. Military Forces
    - 8.4.2.1.2. Homeland Security
    - 8.4.2.1.3. Hospitals & Clinics
    - 8.4.2.1.4. Pharmaceutical & Biotech Companies
    - 8.4.2.1.5. Virological Research Institutes
- 8.4.3. Japan
  - 8.4.3.1. Market Analysis, Insights and Forecast - By End User
    - 8.4.3.1.1. Military Forces
    - 8.4.3.1.2. Homeland Security
    - 8.4.3.1.3. Hospitals & Clinics
    - 8.4.3.1.4. Pharmaceutical & Biotech Companies
    - 8.4.3.1.5. Virological Research Institutes
- 8.4.4. South Korea
  - 8.4.4.1. Market Analysis, Insights and Forecast - By End User
    - 8.4.4.1.1. Military Forces
    - 8.4.4.1.2. Homeland Security
    - 8.4.4.1.3. Hospitals & Clinics
    - 8.4.4.1.4. Pharmaceutical & Biotech Companies
    - 8.4.4.1.5. Virological Research Institutes
- 8.4.5. Rest of Asia Pacific
  - 8.4.5.1. Market Analysis, Insights and Forecast - By End User
    - 8.4.5.1.1. Military Forces
    - 8.4.5.1.2. Homeland Security
    - 8.4.5.1.3. Hospitals & Clinics
    - 8.4.5.1.4. Pharmaceutical & Biotech Companies
    - 8.4.5.1.5. Virological Research Institutes

9. Middle East & Africa Biodefense Market Analysis, Insights and Forecast, 2019-2032

9.1. Market Analysis, Insights and Forecast - By Technology
- 9.1.1. Microwave Heating
- 9.1.2. UV Light
- 9.1.3. Gamma Radiation
- 9.1.4. Cold Plasma
- 9.1.5. Others
9.2. Market Analysis, Insights and Forecast - By System
- 9.2.1. Digital Biosurveillance Networks
- 9.2.2. Early Warning Systems
- 9.2.3. Biohazard Detection Systems
- 9.2.4. AI-Assisted Surveillance System
- 9.2.5. Biosensors
- 9.2.6. Others
9.3. Market Analysis, Insights and Forecast - By End User
- 9.3.1. Military Forces
- 9.3.2. Homeland Security
- 9.3.3. Hospitals & Clinics
- 9.3.4. Pharmaceutical & Biotech Companies
- 9.3.5. Virological Research Institutes
9.4. Market Analysis, Insights and Forecast - By Country
- 9.4.1. Iran
  - 9.4.1.1. Market Analysis, Insights and Forecast - By End User
    - 9.4.1.1.1. Military Forces
    - 9.4.1.1.2. Homeland Security
    - 9.4.1.1.3. Hospitals & Clinics
    - 9.4.1.1.4. Pharmaceutical & Biotech Companies
    - 9.4.1.1.5. Virological Research Institutes
- 9.4.2. Israel
  - 9.4.2.1. Market Analysis, Insights and Forecast - By End User
    - 9.4.2.1.1. Military Forces
    - 9.4.2.1.2. Homeland Security
    - 9.4.2.1.3. Hospitals & Clinics
    - 9.4.2.1.4. Pharmaceutical & Biotech Companies
    - 9.4.2.1.5. Virological Research Institutes
- 9.4.3. Saudi Arabia
  - 9.4.3.1. Market Analysis, Insights and Forecast - By End User
    - 9.4.3.1.1. Military Forces
    - 9.4.3.1.2. Homeland Security
    - 9.4.3.1.3. Hospitals & Clinics
    - 9.4.3.1.4. Pharmaceutical & Biotech Companies
    - 9.4.3.1.5. Virological Research Institutes
- 9.4.4. Turkey
  - 9.4.4.1. Market Analysis, Insights and Forecast - By End User
    - 9.4.4.1.1. Military Forces
    - 9.4.4.1.2. Homeland Security
    - 9.4.4.1.3. Hospitals & Clinics
    - 9.4.4.1.4. Pharmaceutical & Biotech Companies
    - 9.4.4.1.5. Virological Research Institutes
- 9.4.5. Rest of Middle East & Africa
  - 9.4.5.1. Market Analysis, Insights and Forecast - By End User
    - 9.4.5.1.1. Military Forces
    - 9.4.5.1.2. Homeland Security
    - 9.4.5.1.3. Hospitals & Clinics
    - 9.4.5.1.4. Pharmaceutical & Biotech Companies
    - 9.4.5.1.5. Virological Research Institutes

10. Latin America Biodefense Market Analysis, Insights and Forecast, 2019-2032

10.1. Market Analysis, Insights and Forecast - By Technology
- 10.1.1. Microwave Heating
- 10.1.2. UV Light
- 10.1.3. Gamma Radiation
- 10.1.4. Cold Plasma
- 10.1.5. Others
10.2. Market Analysis, Insights and Forecast - By System
- 10.2.1. Digital Biosurveillance Networks
- 10.2.2. Early Warning Systems
- 10.2.3. Biohazard Detection Systems
- 10.2.4. AI-Assisted Surveillance System
- 10.2.5. Biosensors
- 10.2.6. Others
10.3. Market Analysis, Insights and Forecast - By End User
- 10.3.1. Military Forces
- 10.3.2. Homeland Security
- 10.3.3. Hospitals & Clinics
- 10.3.4. Pharmaceutical & Biotech Companies
- 10.3.5. Virological Research Institutes
10.4. Market Analysis, Insights and Forecast - By Country
- 10.4.1. Brazil
  - 10.4.1.1. Market Analysis, Insights and Forecast - By End User
    - 10.4.1.1.1. Military Forces
    - 10.4.1.1.2. Homeland Security
    - 10.4.1.1.3. Hospitals & Clinics
    - 10.4.1.1.4. Pharmaceutical & Biotech Companies
    - 10.4.1.1.5. Virological Research Institutes
- 10.4.2. Argentina
  - 10.4.2.1. Market Analysis, Insights and Forecast - By End User
    - 10.4.2.1.1. Military Forces
    - 10.4.2.1.2. Homeland Security
    - 10.4.2.1.3. Hospitals & Clinics
    - 10.4.2.1.4. Pharmaceutical & Biotech Companies
    - 10.4.2.1.5. Virological Research Institutes
- 10.4.3. Mexico
  - 10.4.3.1. Market Analysis, Insights and Forecast - By End User
    - 10.4.3.1.1. Military Forces
    - 10.4.3.1.2. Homeland Security
    - 10.4.3.1.3. Hospitals & Clinics
    - 10.4.3.1.4. Pharmaceutical & Biotech Companies
    - 10.4.3.1.5. Virological Research Institutes
- 10.4.4. Rest of Latin America
  - 10.4.4.1. Market Analysis, Insights and Forecast - By End User
    - 10.4.4.1.1. Military Forces
    - 10.4.4.1.2. Homeland Security
    - 10.4.4.1.3. Hospitals & Clinics
    - 10.4.4.1.4. Pharmaceutical & Biotech Companies
    - 10.4.4.1.5. Virological Research Institutes

11. Competitive Analysis

11.1. Global Market Rank Analysis (2024)
11.2. Competitive Dashboard

12. Company Profiles

12.1. AirBoss Defense Group, Inc. (U.S.)
- 12.1.1. Overview
- 12.1.2. Products & services
- 12.1.3. SWOT Analysis
- 12.1.4. Recent Developments
- 12.1.5. Strategies
- 12.1.6. Financials (Based on Availability)
12.2. Bioquell, An Ecolab Solution (U.S.)
- 12.2.1. Overview
- 12.2.2. Products & services
- 12.2.3. SWOT Analysis
- 12.2.4. Recent Developments
- 12.2.5. Strategies
- 12.2.6. Financials (Based on Availability)
12.3. Bio-Rad Laboratories, Inc. (U.S.)
- 12.3.1. Overview
- 12.3.2. Products & services
- 12.3.3. SWOT Analysis
- 12.3.4. Recent Developments
- 12.3.5. Strategies
- 12.3.6. Financials (Based on Availability)
12.4. BlueDot Inc. (Canada)
- 12.4.1. Overview
- 12.4.2. Products & services
- 12.4.3. SWOT Analysis
- 12.4.4. Recent Developments
- 12.4.5. Strategies
- 12.4.6. Financials (Based on Availability)
12.5. E4life Srl (Australia)
- 12.5.1. Overview
- 12.5.2. Products & services
- 12.5.3. SWOT Analysis
- 12.5.4. Recent Developments
- 12.5.5. Strategies
- 12.5.6. Financials (Based on Availability)
12.6. Emergent BioSolutions Inc. (U.S.)
- 12.6.1. Overview
- 12.6.2. Products & services
- 12.6.3. SWOT Analysis
- 12.6.4. Recent Developments
- 12.6.5. Strategies
- 12.6.6. Financials (Based on Availability)
12.7. SIGA Technologies, Inc. (U.S.)
- 12.7.1. Overview
- 12.7.2. Products & services
- 12.7.3. SWOT Analysis
- 12.7.4. Recent Developments
- 12.7.5. Strategies
- 12.7.6. Financials (Based on Availability)
12.8. Dynavax Technologies (U.S.)
- 12.8.1. Overview
- 12.8.2. Products & services
- 12.8.3. SWOT Analysis
- 12.8.4. Recent Developments
- 12.8.5. Strategies
- 12.8.6. Financials (Based on Availability)
12.9. Alnylam Pharmaceuticals, Inc. (U.S.)
- 12.9.1. Overview
- 12.9.2. Products & services
- 12.9.3. SWOT Analysis
- 12.9.4. Recent Developments
- 12.9.5. Strategies
- 12.9.6. Financials (Based on Availability)
12.10. Ichor Medical Systems Inc. (U.S.)
- 12.10.1. Overview
- 12.10.2. Products & services
- 12.10.3. SWOT Analysis
- 12.10.4. Recent Developments
- 12.10.5. Strategies
- 12.10.6. Financials (Based on Availability)
12.11. Bavarian Nordic A/S (Denmark)
- 12.11.1. Overview
- 12.11.2. Products & services
- 12.11.3. SWOT Analysis
- 12.11.4. Recent Developments
- 12.11.5. Strategies
- 12.11.6. Financials (Based on Availability)
12.12. SKAN AG (Switzerland)
- 12.12.1. Overview
- 12.12.2. Products & services
- 12.12.3. SWOT Analysis
- 12.12.4. Recent Developments
- 12.12.5. Strategies
- 12.12.6. Financials (Based on Availability)
12.13. Smiths Detection Group Ltd (U.K.)
- 12.13.1. Overview
- 12.13.2. Products & services
- 12.13.3. SWOT Analysis
- 12.13.4. Recent Developments
- 12.13.5. Strategies
- 12.13.6. Financials (Based on Availability)
12.14. Parsons Corporation (U.S.)
- 12.14.1. Overview
- 12.14.2. Products & services
- 12.14.3. SWOT Analysis
- 12.14.4. Recent Developments
- 12.14.5. Strategies
- 12.14.6. Financials (Based on Availability)

Product Code: FBI113684

List of Tables

Table 1: Global Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 2: Global Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 3: Global Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 4: Global Biodefense Market (USD Bn) Forecast, By Region, 2019-2032
Table 5: North America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 6: North America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 7: North America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 8: North America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
Table 9: U.S. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 10: Canada Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 11: Europe Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 12: Europe Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 13: Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 14: Europe Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
Table 15: U.K. Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 16: Germany Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 17: France Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 18: Russia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 19: Rest of Europe Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 20: Asia Pacific Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 21: Asia Pacific Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 22: Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 23: Asia Pacific Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
Table 24: China Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 25: India Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 26: Japan Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 27: South Korea Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 28: Rest of Asia Pacific Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 29: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 30: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 31: Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 32: Middle East & Africa Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
Table 33: Iran Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 34: Israel Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 35: Saudi Arabia Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 36: Turkey Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 37: Rest of Middle East & Africa Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 38: Latin America Biodefense Market, (USD Bn) Forecast, By Technology, 2019-2032
Table 39: Latin America Biodefense Market, (USD Bn) Forecast, By System, 2019-2032
Table 40: Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 41: Latin America Biodefense Market (USD Bn) Forecast, By Country, 2019-2032
Table 42: Brazil Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 43: Argentina Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 44: Mexico Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032
Table 45: Rest of Latin America Biodefense Market, (USD Bn) Forecast, By End User, 2019-2032

List of Figures

Figure 1: Global Biodefense Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2032
Figure 2: Global Biodefense Market (%) Breakdown By Technology, 2024 & 2032
Figure 3: Global Biodefense Market (USD Bn) Breakdown By Microwave Heating, 2019-2032
Figure 4: Global Biodefense Market (USD Bn) Breakdown By UV Light, 2019-2032
Figure 5: Global Biodefense Market (USD Bn) Breakdown By Gamma Radiation, 2019-2032
Figure 6: Global Biodefense Market (USD Bn) Breakdown By Cold Plasma, 2019-2032
Figure 7: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
Figure 8: Global Biodefense Market (%) Breakdown By System, 2024 & 2032
Figure 9: Global Biodefense Market (USD Bn) Breakdown By Digital Biosurveillance Networks, 2019-2032
Figure 10: Global Biodefense Market (USD Bn) Breakdown By Early Warning Systems, 2019-2032
Figure 11: Global Biodefense Market (USD Bn) Breakdown By Biohazard Detection Systems, 2019-2032
Figure 12: Global Biodefense Market (USD Bn) Breakdown By AI-Assisted Surveillance System, 2019-2032
Figure 13: Global Biodefense Market (USD Bn) Breakdown By Biosensors, 2019-2032
Figure 14: Global Biodefense Market (USD Bn) Breakdown By Others, 2019-2032
Figure 15: Global Biodefense Market (%) Breakdown By End User, 2024 & 2032
Figure 16: Global Biodefense Market (USD Bn) Breakdown By Military Forces, 2019-2032
Figure 17: Global Biodefense Market (USD Bn) Breakdown By Homeland Security, 2019-2032
Figure 18: Global Biodefense Market (USD Bn) Breakdown By Hospitals & Clinics, 2019-2032
Figure 19: Global Biodefense Market (USD Bn) Breakdown By Pharmaceutical & Biotech Companies, 2019-2032
Figure 20: Global Biodefense Market (USD Bn) Breakdown By Virological Research Institutes, 2019-2032
Figure 21: Global Biodefense Market Share (%) By Region, 2024 & 2032
Figure 22: North America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
Figure 23: North America Biodefense Market Value Share (%) By Technology, 2024
Figure 24: North America Biodefense Market Value (USD Bn) By System, 2024 & 2032
Figure 25: North America Biodefense Market Value Share (%) By System, 2024
Figure 26: North America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 27: North America Biodefense Market Value Share (%) By End User, 2024
Figure 28: North America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
Figure 29: North America Biodefense Value Share (%) By Country, 2024
Figure 30: U.S. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 31: U.S. Biodefense Market Value Share (%) By End User, 2024
Figure 32: Canada Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 33: Canada Biodefense Market Value Share (%) By End User, 2024
Figure 34: Europe Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
Figure 35: Europe Biodefense Market Value Share (%) By Technology, 2024
Figure 36: Europe Biodefense Market Value (USD Bn) By System, 2024 & 2032
Figure 37: Europe Biodefense Market Value Share (%) By System, 2024
Figure 38: Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 39: Europe Biodefense Market Value Share (%) By End User, 2024
Figure 40: Europe Biodefense Market Value (USD Bn) By Country, 2024 & 2032
Figure 41: Europe Biodefense Value Share (%) By Country, 2024
Figure 42: U.K. Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 43: U.K. Biodefense Market Value Share (%) By End User, 2024
Figure 44: Germany Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 45: Germany Biodefense Market Value Share (%) By End User, 2024
Figure 46: France Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 47: France Biodefense Market Value Share (%) By End User, 2024
Figure 48: Russia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 49: Russia Biodefense Market Value Share (%) By End User, 2024
Figure 50: Rest of Europe Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 51: Rest of Europe Biodefense Market Value Share (%) By End User, 2024
Figure 52: Asia Pacific Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
Figure 53: Asia Pacific Biodefense Market Value Share (%) By Technology, 2024
Figure 54: Asia Pacific Biodefense Market Value (USD Bn) By System, 2024 & 2032
Figure 55: Asia Pacific Biodefense Market Value Share (%) By System, 2024
Figure 56: Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 57: Asia Pacific Biodefense Market Value Share (%) By End User, 2024
Figure 58: Asia Pacific Biodefense Market Value (USD Bn) By Country, 2024 & 2032
Figure 59: Asia Pacific Biodefense Value Share (%) By Country, 2024
Figure 60: China Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 61: China Biodefense Market Value Share (%) By End User, 2024
Figure 62: India Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 63: India Biodefense Market Value Share (%) By End User, 2024
Figure 64: Japan Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 65: Japan Biodefense Market Value Share (%) By End User, 2024
Figure 66: South Korea Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 67: South Korea Biodefense Market Value Share (%) By End User, 2024
Figure 68: Rest of Asia Pacific Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 69: Rest of Asia Pacific Biodefense Market Value Share (%) By End User, 2024
Figure 70: Middle East & Africa Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
Figure 71: Middle East & Africa Biodefense Market Value Share (%) By Technology, 2024
Figure 72: Middle East & Africa Biodefense Market Value (USD Bn) By System, 2024 & 2032
Figure 73: Middle East & Africa Biodefense Market Value Share (%) By System, 2024
Figure 74: Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 75: Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
Figure 76: Middle East & Africa Biodefense Market Value (USD Bn) By Country, 2024 & 2032
Figure 77: Middle East & Africa Biodefense Value Share (%) By Country, 2024
Figure 78: Iran Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 79: Iran Biodefense Market Value Share (%) By End User, 2024
Figure 80: Israel Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 81: Israel Biodefense Market Value Share (%) By End User, 2024
Figure 82: Saudi Arabia Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 83: Saudi Arabia Biodefense Market Value Share (%) By End User, 2024
Figure 84: Turkey Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 85: Turkey Biodefense Market Value Share (%) By End User, 2024
Figure 86: Rest of Middle East & Africa Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 87: Rest of Middle East & Africa Biodefense Market Value Share (%) By End User, 2024
Figure 88: Latin America Biodefense Market Value (USD Bn) By Technology, 2024 & 2032
Figure 89: Latin America Biodefense Market Value Share (%) By Technology, 2024
Figure 90: Latin America Biodefense Market Value (USD Bn) By System, 2024 & 2032
Figure 91: Latin America Biodefense Market Value Share (%) By System, 2024
Figure 92: Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 93: Latin America Biodefense Market Value Share (%) By End User, 2024
Figure 94: Latin America Biodefense Market Value (USD Bn) By Country, 2024 & 2032
Figure 95: Latin America Biodefense Value Share (%) By Country, 2024
Figure 96: Brazil Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 97: Brazil Biodefense Market Value Share (%) By End User, 2024
Figure 98: Argentina Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 99: Argentina Biodefense Market Value Share (%) By End User, 2024
Figure 100: Mexico Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 101: Mexico Biodefense Market Value Share (%) By End User, 2024
Figure 102: Rest of Latin America Biodefense Market Value (USD Bn) By End User, 2024 & 2032
Figure 103: Rest of Latin America Biodefense Market Value Share (%) By End User, 2024
Figure 104: Global Biodefense Market Rank Analysis, By Key Players, 2024

Biodefense Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Description

Table of Contents

List of Tables

Growth Factors of biodefense Market

Regional Insights

Table of Content

1. Introduction

2. Executive Summary

3. Market Dynamics

4. Key Insights

5. Global Biodefense Market Analysis, Insights and Forecast, 2019-2032

6. North America Biodefense Market Analysis, Insights and Forecast, 2019-2032

7. Europe Biodefense Market Analysis, Insights and Forecast, 2019-2032

8. Asia Pacific Biodefense Market Analysis, Insights and Forecast, 2019-2032

9. Middle East & Africa Biodefense Market Analysis, Insights and Forecast, 2019-2032

10. Latin America Biodefense Market Analysis, Insights and Forecast, 2019-2032

11. Competitive Analysis

12. Company Profiles

List of Tables

List of Figures